Summary Alterations in the connective tissue of the arterial wall have been suggested to play a role in the development of macrovascular disease in diabetes mellitus. The present study deals with changes in the content of GAG in aortic tunica media in human diabetes by separately analysing normal areas and areas with fibrous plaques. The thoracic aorta from 15 diabetic patients (7 with IDDM, 8 with NIDDM), and 30 sex-and age-matched non-diabetic subjects were collected at autopsy. Tunica intima was removed and GAG were isolated from the dried defatted and pulverized tunica media. GAG were quantified by uronic acid analysis and characterized by electrophoresis on cellulose acetate. Results showed that IDDM patients had a relative and absolute increase in hyaluronic acid in normal tunica media compared to non-diabetic subjects. There was a significant positive correlation between hyaluronic acid content of normal tunica media and duration of diabetes, but not between hyaluronic acid content and age. When tunica media from plaque areas was compared to normal areas the same pattern was evident in diabetic patients as in non-diabetic patients -significantly increased proportion of dermatan sulphate and reduced hyaluronic acid. The data agree with the notion that the arterial wall is subject to different pathological processes in diabetes, one of classical atherosclerosis with changes in GAG similar to non-diabetic subjects, and the other seen in areas without plaques with dissimilar alterations in GAG. These data therefore support the concept of the presence of a macrovascular disease in diabetes different from atherosclerosis. [Diabetologia (1994) 37: 286-292] 
the large vessel disease cannot be explained solely as accelerated atherosclerosis [1] . Several investigations point toward primary alterations in the arterial wall in the diabetic patients. Proliferation of smooth muscle cells with increased periodic acid-Schiff positive substance in the extracellular matrix in the coronary arteries [2] [3] [4] [5] and linear arterial calcification in tunica media [6, 7] have been described in diabetes. In aorta from diabetic subjects fibronectin and type IV collagen accumulate in tunica media independent of the presence of atherosclerotic plaque [8, 9] and non-atherosclerotic areas of aorta have shown altered mechanical properties with significantly increased stiffness [10] indicating that alterations occur in the connective tissue of the arterial wall in diabetes.
It has been suggested that changes in the content or distribution of GAG in the arterial wall may occur in Values are presented as mean + SD. a Infections, accidents etc.
diabetes. Morphological studies of diabetic arteries have shown decreased Alcian blue staining suggesting either a decreased GAG content or altered sulphation of the macromolecules [3] . Data from some studies of experimental diabetes have pointed to an increased hyaluronic acid content in rodent aorta [11, 12] , others have given less clear results [13] , however, there is no information available about the distribution of GAG in tunica media of the human aorta in diabetes. GAG/proteoglycans are considered to be involved in some of the key events which lead to the formation of atherosclerotic lesions [14] , e. g. binding of lipoproteins [15, 16] , platelet aggregation [17] , and growth inhibition of smooth muscle cells [18] . Alterations in these macromolecules in diabetes could therefore play a significant role in the development of large vessel disease in diabetes.
This study presents the first information about the content and distribution of GAG in tunica media of the human aorta in diabetes analysing separately tunica media from areas with and without atherosclerotic plaque.
Subjects and methods

Patients
The descending part of the thoracic aorta was collected at autopsy from 15 diabetic patients: seven with IDDM and eight with NIDDM. For each diabetic patient two sex and age-matched non-diabetic subjects were included. The aortic samples were in all cases obtained within 40 h of death. Exclusion criteria were: connective tissue diseases, glucocorticoid treatment, administration of chemotherapeutics or radiotherapy to the thoracic region. Basal clinical data of diabetic patients and control subjects are given in Table 1 . Patients treated for hypertension or with more than one blood pressure measurement over 140/ 100 mm Hg were considered to be hypertensive.
Aortas
The descending part of the thoracic aorta was removed and washed in 0.9 % NaC1, 10 mmol/1 Tris/HC1 (pH 7.4) containing proteinase inhibitors (0.5 mmol/1N-ethyl-maleimide, 0.5 mmol/1 phenylmethylsulphonyl fluoride, I mmol/1 benzamidine hydrochloride) and kept at -80 ~ until analysis. After thawing tunica adventitia was removed and intima-media samples were taken from areas with apparently normal intimal surface as well as from areas with plaque seen as yellowish/white elevated lesions. Normal intima was defined as areas without any discolorations or elevation of the surface, whereas regions with elevated white areas without ulceration, aneurysms or thrombosis were considered as uncomplicated fibrous plaque. Tunica intima was carefully removed from tunica media by blunt dissection. Histological examination confirmed that the tissue was split close to the internal elastic membrane. The samples were lyophilized, weighed, and defatted by two 24-h extractions in chloroformethanol (3:1). The samples were lyophilized and weighed. The dry defatted tissue was pulverized in a Retsch Mill (E Kurt Retsch GMBH, Haan, Germany), and stored at -80~ until analysis.
Isolation of GAG
The GAG were isolated from 10-30 mg of dry defatted tissue as described in detail previously [19] . Tunica media samples were digested with papain, 5 Bg/mg dry defatted tissue for 20 h at 65 ~ GAG were precipitated with cetyl pyridinium chloride at a final concentration of 0.5 %. Cetyl pyridinium chloride-GAG complexes were dissolved in n-propanol and further purified by precipitation twice with ethanol containing 2 % potassium acetate. GAG were dissolved in distilled water and quantified on the basis of uronic acid content [20] . The efficacy of the proteolytic digestion procedure was evaluated by measuring the hexosamine content of the insoluble precipitate of the samples [21] . The data showed that 95-97 % of the GAG were liberated by the present procedure. Recovery was estimated by adding known amounts of purified GAG to samples of dry defatted tissue, and was found to be 90-97 %. The results were not corrected for recovery.
Identification of GAG
Isolated GAG were separated by electrophoresis on cellulose acetate (Titan III, Helena Laboratories, Beaumont, Tx., USA). The samples were analysed in triplicate using two different buffer systems; a)electrophoresis in 0.3 mol/1 cadmium acetate, pH 4.1 [22] , and b) electrophoresis in 0.1 mol/1 barium acetate, pH 5.0 [23] . In cadmium acetate hyaluronic acid was well separated from heparan sulphate and dermatan/chondroitin sulphates, whereas the chondroitin sulphate fraction was determined using the barium acetate buffer system. After staining in 0.1% Alcian blue the distribution of GAG was quantified by densitometry using a Shimazdu scanning spectrophotometer at 610 nm, beam size 0.05 x 2 mm. The average variation (between runs) of the electrophoretic analysis of samples was 2~5 %. On each membrane a mixture of standards was co-electrophoresed. The following GAG were used as standards: hyaluronic acid from human umbilical cord, chondroitin sulphate A from bovine trachea, chondroitin sulphate C from shark cartilage, dermatan sulphate from porcine skin, heparan sulphate from bovine kidney, all obtained from Sigma (St. Louis, Mo., USA). The difference in Alcian blue binding capacity of the various GAG was determined and the data were compensated accordingly. Relative to hyaluronic acid the following factors were used: chondroitin sulphate 0.6, dermatan sulphate 0.6, heparan sulphate 0.8. The distribution/content of the GAG types was expressed as a fraction of total GAG (%) and as gg GAG per mg dry defatted tissue.
Statistical analysis
Statistical evaluation was performed by non-parametrical analyses using the Wilcoxon test. Comparisons between variables were made using Spearman's Rank Correlation analysis. A p value of less than 0.05 was considered significant.
Results
T h e clinical characteristics of the two diabetic patient groups and the non-diabetic control groups are given in Table 1 . T h e r e was no statistically significant difference in time b e t w e e n d e a t h and examination in either of the groups examined. Mean percentages of total GAG + SEM are given for seven IDDM patients (DM1), eight NIDDM patients (DM2) and two groups of non-diabetic subjects matched for age and sex (C1, n = 14; and C2, n = 16).
Diabetic groups compared to non-diabetic groups
patient group there was a trend towards increased hyaluronic acid fraction in tunica media from nonatherosclerotic areas of the vessel, but the difference failed to meet statistical significance (12.0 % hyaluronic acid vs 8.9%, mean values, 0.05<2p < 0.10). We found no statistically significant differences in the proportion of heparan sulphate, dermatan sulphate or chondroitin sulphate between the diabetic patients and their control groups in samples of tunica media from non-atherosclerotic areas of aorta (Fig. 3) .
When the results were calculated in absolute terms on the basis of uronic acid content, the IDDM patient group had an increased amount of hyaluronic acid per mg dry defatted tissue (mean gg hyaluronic acid per mg dry defatted tissue: 2.67 pg vs 1.41 gg, 2p < 0.01, not shown). We found no statistically significant difference in heparan sulphate content, dermatan sulphate or chondroitin sulphate per mg dry defatted tissue when comparing the diabetic patient groups to the control groups.
Distribution of GAG in tunica media from areas with plaque. When samples of tunica media from areas with plaques were examined the proportion of the various GAG types in both IDDM and NIDDM patient groups was similar to that of the control groups (Fig. 4) .
GAG and duration of diabetes.
The relationship between the duration of diabetes of all diabetic patients and hyaluronic acid content or hyaluronic acid fraction 
Tunica media from plaque areas compared to non-plaque areas
The total amount of GAG from tunica media of plaque areas was significantly decreased compared to normal areas of aorta. The difference was significant in both the combined non-diabetic groups (2p < 0.01) and in the IDDM group (2p < 0.01), but not in the NIDDM patient group. The following mean values of pg GAG per mg dry defatted tissue were found in nonplaque/plaque areas: IDDM group, 15.2 pg/10.4 pg; NIDDM group, 10.3 pg/8.6 gg; non-diabetic groups combined, 13.8 gg/9.5 pg.
When the proportion of the various GAG in tunica media was analysed comparing plaque areas to normal areas the most consistent findings were increased dermatan sulphate and decreased hyaluronic acid fractions. Tunica media from plaque areas of aorta had a significantly increased dermatan sulphate fraction. This was true both for IDDM and NIDDM patients as well as for the non-diabetic subjects (IDDM patients: 2p < 0.01, NIDDM patients: 2p < 0.05, and non-diabetic subjects: 2p < 0.01) (Fig. 6) . In tunica media of aorta from IDDM patients we found a significantly decreased proportion of hyaluronic acid in plaque areas of the vessel compared to macroscopically normal areas (2/) < 0.05). Also expressed per mg dry defatted tissue the hyaluronic acid content was less in tunica media samples from areas with plaque in IDDM patients (2/) < 0.02). The same pattern was seen in nondiabetic subjects, as we observed decreased amounts of hyaluronic acid in tunica media from plaque areas of aorta (2p < 0.01). In NIDDM patients the difference in hyaluronic acid fraction in tunica media between plaque areas and normal areas of aorta was not statistically significant.
Discussion
Previous reports have shown alterations in several extracellular matrix components, such as accmnulation of fibronectin and type IV collagen in arteries from diabetic patients [8, 9] . In the present study which focuses on another class of extracellular matrix components, GAG, we found increased hyaluronic acid content in aortas from diabetic patients. This result agrees with earlier studies of experimental diabetes performed on alloxan-diabetic rodents where it was observed that hyaluronic acid accumulated in tunica media-intima samples from the aorta of diabetic animals, without any changes in total GAG content or L. Heickendorff et al.: GAG in aorta in diabetes
Comparison between tunica media from areas of aorta without plaque ( -P) and with plaque ( + P). Proportions of hyaluronic acid (A) and dermatan sulphate (B) in tunica media of aorta from seven IDDM patients (DM1), eight NIDDM patients (DM2) and 30 non-diabetic subjects (C) are shown. Data are given as percentages of total GAG, mean values + SEM. ** 2p < 0.01. * 2p < 0.05 concentration of heparan sulphate [11, 12] . Hyaluronic acid is secreted by arterial smooth muscle cells [24] , and it is interesting to note that diabetic serum enhances the secretion of hyaluronic acid from cultured human aortic smooth muscle cells [25, 26] . Factors in the diabetic metabolism may stimulate hyaluronic acid synthesis leading to tissue accumulation of this substance in the tunica media of arteries, as we report here. In support of this view is the fact that we could demonstrate a statistically significant relationship between hyaluronic acid content in mnica media and duration of diabetes. This relationship did not reflect influence of age, since hyaluronic acid concentration did not show a positive correlation to age in either diabetic or control subjects. The accumulation of hyaluronic acid in tunica media of aorta could also be related to increased growth rates of vascular smooth muscle cells in diabetes which has been suggested [4, 27, 28] . Previous studies of arterial smooth muscle cells in vitro have shown that the cells increase their activity of hyaluronic acid synthesizing enzymes during proliferation [29] , and that growth-stimulated cells increase the secretion of hyaluronic acid [30] . Studies with other cell types support this notion, since it has been reported that hyaluronic acid synthesis is related to cell proliferation in fibroblasts [31] , and that hyaluronic acid synthesis may be regulated by growth regulating factors, such as transforming growth factor/3 and plateletderived growth factor [32, 33] .
Data from in vitro labelling techniques have suggested that aortic tissue from diabetic animals display decreased synthesis of heparan sulphate and also other sulphated GAG [11, 34] . A reduction in heparan sulphate content has been demonstrated in the kidney/glomerular basement membranes in diabetes [35, 36] . However, we did not find any reduction in heparan sulphate content of tunica media in the diabetic aorta, either when expressed in absolute amount per mg dry defatted tissue or as a percentage of total GAG. This observation indicates that the decrease in heparan sulphate content seen in glomerular basement membranes in diabetes cannot be conceived as a generalized alteration, but depends on the tissue examined. Furthermore, a recent study of the intimal layer of aorta from NIDDM patients showed no significant change in heparan sulphate content [37] . In this study an increased dermatan sulphate content was observed without any significant changes in other GAG. It is difficult to relate this finding to the results of our study, as the intimal and medial layers of aorta have a quite different composition including paramount differences in GAG content [38] .
The changes we have found in tunica media from plaque areas comprising increased proportion of dermatan sulphate, but decreased hyaluronic acid are consistent with the findings of more recent studies of aorta from non-diabetic subjects. Many investigators have studied the GAG content of normal and atherosclerotic arteries with at times rather inconsistent findings [19, [38] [39] [40] [41] [42] . However, most of the more recent studies on human coronary arteries agree that dermatan sulphate increases in tunica media in atherosclerosis [19, 40] . In the human aorta some investigators have observed increased dermatan sulphate-chondroitin sulphate [42] , but others did not find any significant changes in tunica media in atherosclerosis [38] . In experimentally-induced atherosclerosis in primate aorta the most significant observation was increased dermatan sulphate [41] which is in agreement with our results. With regard to hyaluronic acid and atherosclerosis there are several reports which indicate that hyaluronic acid decreases with atherosclerotic involvement of tunica media [19, [39] [40] [41] .
Considering hyaluronic acid there was some similarity in our data of IDDM and NIDDM patients, but when focusing on total GAG content the results are discordant, as only NIDDM patients had a reduced GAG content. The observed difference may be related to older age and shorter diabetes duration of the NIDDM group, as these factors may be associated with a decreased GAG content.
It is remarkable that the changes we have found in normal areas of tunica media in diabetes are different from the changes observed in atheroscler0tic plaques with respect to hyaluronic acid proportion. It appears that the extracellular matrix of the arterial wall in diabetes is subject to different pathological processes.
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In areas with atherosclerotic plaque, a reduction in hyaluronic acid is seen and this alteration together with accumulation of dermatan sulphate is similar to that seen in non-diabetic subjects. But in areas of aorta with macroscopically normal luminal surface an increased proportion of hyaluronic acid is observed in tunica media in diabetes. In our previous studies we observed accumulation of extracellular matrix components, such as fibronectin, and type IV collagen in tunica media of aorta in diabetes independent of the presence of atherosclerotic plaques [8, 9] . These findings together with the data of the present study strongly support the concept of a diabetic macrovascular disease which is different from classic atherosclerosis.
